Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA and Sitagliptin in Type 2 Diabetes and Chronic Liver Disease
NCT01337440Phase 4Unknown
- Sponsor
- Kanazawa University
- Start
- Apr 2010
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ursodeoxycholic acid in type 2 diabetes mellitus (T2DM), sponsored by Kanazawa University. Status: unknown.
02
Drugs
ursodeoxycholic acid
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01337440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01337440.